HighTower Advisors’s ImmuCell ICCC Stock Holding History

HighTower Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$154K	Buy	24,354 +5,000	+26%	+$32K	﹤0.01%	3555
2025 Q4	$119K	Sell	19,354 -2,000	-9%	-$11.8K	﹤0.01%	3478
2025 Q3	$138K	Hold	21,354	–	–	﹤0.01%	3476
2025 Q2	$149K	Hold	21,354	–	–	﹤0.01%	3388
2025 Q1	$102K	Hold	21,354	–	–	﹤0.01%	3352
2024 Q4	$110K	Hold	21,354	–	–	﹤0.01%	3358
2024 Q3	$77K	Hold	21,354	–	–	﹤0.01%	3354
2024 Q2	$103K	Sell	21,354 -100	-0.5%	-$481	﹤0.01%	3201
2024 Q1	$115K	Buy	21,454 +100	+0.5%	+$515	﹤0.01%	3122
2023 Q4	$108K	Hold	21,354	–	–	﹤0.01%	3179
2023 Q3	$111K	Hold	21,354	–	–	﹤0.01%	3073
2023 Q2	$109K	Hold	21,354	–	–	﹤0.01%	3056
2023 Q1	$110K	Hold	21,354	–	–	﹤0.01%	2920
2022 Q4	$131K	Hold	21,354	–	–	﹤0.01%	2897
2022 Q3	$160K	Buy	21,354 +3,000	+16%	+$24.5K	﹤0.01%	2657
2022 Q2	$159K	Hold	18,354	–	–	﹤0.01%	2682
2022 Q1	$177K	Buy	18,354 +100	+0.5%	+$863	﹤0.01%	2871
2021 Q4	$146K	Hold	18,254	–	–	﹤0.01%	2852
2021 Q3	$169K	Buy	18,254 +2,500	+16%	+$23.7K	﹤0.01%	2754
2021 Q2	$150K	Hold	15,754	–	–	﹤0.01%	2728
2021 Q1	$152K	Sell	15,754 -1,120	-7%	-$10.5K	﹤0.01%	2672
2020 Q4	$101K	Buy	16,874 +3,500	+26%	+$20.4K	﹤0.01%	2350
2020 Q3	$73K	Hold	13,374	–	–	﹤0.01%	2273
2020 Q2	$62K	Hold	13,374	–	–	﹤0.01%	2183
2020 Q1	$51K	Sell	13,374 -1,600	-11%	-$7.88K	﹤0.01%	2008
2019 Q4	$77K	Buy	+14,974	New	+$77.2K	﹤0.01%	2098

Other funds holding ICCC

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.18B AUM 18.43% 1-Year Est. Return

HighTower Advisors's ICCC Position: Q1 2026 in Review

HighTower Advisors increased its ImmuCell (ICCC) stake by 26% in Q1 2026, buying an estimated $32K and bringing the position to 24,354 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #3555.

HighTower Advisors first reported a position in ICCC in Q4 2019 and has held it in 26 quarters since. The position peaked at $177K in Q1 2022. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.

HighTower Advisors held 24,354 shares of ImmuCell worth $154K as of Q1 2026.
HighTower Advisors bought 5,000 ImmuCell shares in Q1 2026, an estimated $32K.
ImmuCell made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3555 holding.
HighTower Advisors first reported a position in ImmuCell in Q4 2019 and has held it in 26 quarters since.
HighTower Advisors's ImmuCell position peaked at $177K in Q1 2022.
27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.